These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30864043)

  • 41. Association of serum uric acid level with cognitive function among patients with multiple system atrophy.
    Cao B; Wei QQ; Ou R; Yang J; Shang HF
    J Neurol Sci; 2015 Dec; 359(1-2):363-6. PubMed ID: 26671143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical features associated with drooling in Parkinson's disease.
    Nascimento D
    Neurol Sci; 2021 Mar; 42(3):895-903. PubMed ID: 33443673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.
    Karakoc M; Yon MI; Cakmakli GY; Ulusoy EK; Gulunay A; Oztekin N; Ak F
    Neurol Sci; 2016 Dec; 37(12):1987-1991. PubMed ID: 27613712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.
    Winter Y; Spottke AE; Stamelou M; Cabanel N; Eggert K; Höglinger GU; Sixel-Doering F; Herting B; Klockgether T; Reichmann H; Oertel WH; Dodel R
    Neurodegener Dis; 2011; 8(6):438-46. PubMed ID: 21576919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions.
    Saleem TZ; Higginson IJ; Chaudhuri KR; Martin A; Burman R; Leigh PN
    Palliat Med; 2013 Sep; 27(8):722-31. PubMed ID: 23208011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study.
    Foubert-Samier A; Pavy-Le Traon A; Guillet F; Le-Goff M; Helmer C; Tison F; Rascol O; Proust-Lima C; Meissner WG
    Neurobiol Dis; 2020 Jun; 139():104813. PubMed ID: 32087288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.
    Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H
    Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.
    Cao B; Zhao B; Wei QQ; Chen K; Yang J; Ou R; Wu Y; Shang HF
    PLoS One; 2015; 10(10):e0139773. PubMed ID: 26431430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
    Rascol O; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Fabbri M; Meissner WG; Rachdi A; Tison F; Perez-Lloret S;
    J Neural Transm (Vienna); 2020 Dec; 127(12):1607-1617. PubMed ID: 32880023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy.
    Gatto E; Rodríguez-Violante M; Cosentino C; Chana-Cuevas P; Miranda M; Gallin E; Etcheverry JL; Nuñez Y; Parisi V; Persi G; Vecchi C; Sanguinetti A; Alleva A; Aparcana J; Torres L; Litvan I
    J Parkinsons Dis; 2014; 4(4):693-8. PubMed ID: 25213997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The natural history of multiple system atrophy: a prospective European cohort study.
    Wenning GK; Geser F; Krismer F; Seppi K; Duerr S; Boesch S; Köllensperger M; Goebel G; Pfeiffer KP; Barone P; Pellecchia MT; Quinn NP; Koukouni V; Fowler CJ; Schrag A; Mathias CJ; Giladi N; Gurevich T; Dupont E; Ostergaard K; Nilsson CF; Widner H; Oertel W; Eggert KM; Albanese A; del Sorbo F; Tolosa E; Cardozo A; Deuschl G; Hellriegel H; Klockgether T; Dodel R; Sampaio C; Coelho M; Djaldetti R; Melamed E; Gasser T; Kamm C; Meco G; Colosimo C; Rascol O; Meissner WG; Tison F; Poewe W;
    Lancet Neurol; 2013 Mar; 12(3):264-74. PubMed ID: 23391524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Profile and Evolution of Neuropsychiatric Symptoms in Multiple System Atrophy: Self- and Caregiver Report.
    Jecmenica-Lukic M; Petrovic IN; Pekmezovic T; Tomic A; Stankovic I; Svetel M; Kostic VS
    J Neuropsychiatry Clin Neurosci; 2021; 33(2):124-131. PubMed ID: 33261525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depression and associated factors in nondemented Chinese patients with Parkinson's disease.
    Zhu J; Lu L; Pan Y; Shen B; Xu S; Hou Y; Zhang X; Zhang L
    Clin Neurol Neurosurg; 2017 Dec; 163():142-148. PubMed ID: 29102870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
    Evatt ML; Chaudhuri KR; Chou KL; Cubo E; Hinson V; Kompoliti K; Yang C; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2009 Apr; 24(5):635-46. PubMed ID: 19205066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study.
    van Wamelen DJ; Leta V; Johnson J; Ocampo CL; Podlewska AM; Rukavina K; Rizos A; Martinez-Martin P; Chaudhuri KR
    Dysphagia; 2020 Dec; 35(6):955-961. PubMed ID: 32130515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Scarpel RD; Neves CA; Melo A
    Parkinsonism Relat Disord; 2008; 14(3):243-5. PubMed ID: 17892967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of Early Oropharyngeal Dysphagia in Patients with Multiple System Atrophy.
    Lee HH; Seo HG; Kim KD; Lee SH; Lee WH; Oh BM; Lee WW; Kim Y; Kim A; Kim HJ; Jeon B; Han TR
    Neurodegener Dis; 2018; 18(2-3):84-90. PubMed ID: 29621788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.